No Data
No Data
Alfressa HD, MonotaRO, etc. (additional) Rating
Downgrade - Bearish Code Stock Name Securities Company Previous Change After ------------------------------------------------------------ <3659> Nexon Macquarie "Outperform" "Neutral" <6273> SMC Macquarie "Outperform" "Neutral" <6841> Yokogawa Electric Daiwa "2" "3" Target Price Change Code Stock Name Securities Company Previous Change After --------------------
Rating information (Target Price change - Part 1) = Ship HD, Astellas Pharma, ETC.
Nomura Securities (three-tier: Buy > neutral > Reduce) Ship HD <3360.T> ―― "Buy" → "Buy", 3,430 yen → 3,150 yen Miura Industries <6005.T> ―― "Buy" → "Buy", 5,200 yen → 4,700 yen Sysmex <6869.T> ―― "Buy" → "Buy", 3,800 yen → 3,900 yen NX HD <9147.T> ―― "Buy" → "Buy", 2,933 yen → 3,500 yen Alfresa <2784.T> ―― "neutral".
MITSUBISHI ESTATE, 3Q operating profit increased by 32.5% to 194.4 billion yen.
MITSUBISHI ESTATE <8802> announced its financial results for the third quarter of the fiscal year ending March 2025, with operating revenue increasing by 13.1% year-on-year to 1 trillion 47.9 billion 19 million yen, and operating profit rising by 32.5% to 194.4 billion 78 million yen. Both income and capital gains are progressing smoothly towards the company's full-year financial estimates. In Japan, the stable Market Overview is being leveraged, leading to an increase in capital gains. Additionally, the Brokerage business is performing well. [Positive Evaluation] <8802> MITSUBISHI ESTATE Q4| <7740> TAMRON
Ship Healthcare Holdings Reports Strong Financial Performance for Nine Months Ending December 2024
Ship Healthcare Holdings Sees FY Net Y15.00B
Ship Healthcare Holdings: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)
Shareholders in Far East Horizon (HKG:3360) Are in the Red If They Invested Three Years Ago